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Aim. The aim of this study is to validate high-resolution endovaginal T2- and diffusion-weighted MRI mea-
surements (tumour size, volume and length of uninvolved cervical canal) against histology in patients undergo-
ing trachelectomy.
Patients/interventions. 55 consecutive patients 25–44 years with cervical cancer being considered for
trachelectomy were prospectively assessed with endovaginal T2-W and diffusion-weighted MRI. Two indepen-
dent observers blinded to histology recorded maximum tumour dimension, volume and distance from the
superior aspect of the tumour to the internal os. Following trachelectomy, pathologist-outlined tumour sections
were photographed with a set scale and similar measurements were recorded.
Results. Fifteen of 45 patients subsequently treated with fertility-sparing surgery had residual tumour
(median histological volume: 0.28 cm3, IQR = 0.14–1.06 cm3). Sensitivity, speciﬁcity, positive and negative
predictive values for detecting tumour: Observer1: 86.7%, 80.0%, 68.4%, and 92.3%, respectively; Observer2:
86.7%, 90.0%, 81.0%, and 93.1%, respectively. Size and volume correlated between observers (r = 0.96, 0.84,
respectively, p b 0.0001). Size correlated between each observer and histology (observer 1 r = 0.91, p b 0.0001;
observer 2 r = 0.93, p b 0.0001), volume did not (observer 1: r = 0.08, p = 0.6; observer 2: r = 0.21,
p = 0.16); however, differences between observer measurements and histology were not signiﬁcant
(size p = 0.09, volume p = 0.15). Differences between MRI and histology estimates of endocervical
canal length were not signiﬁcant (p = 0.1 both observers).
Conclusion. In subcentimetre cervical cancers, endovaginal MRI correlates with pathology and is
invaluable in assessing patients for fertility-sparing surgery.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).g Centre, Institute of Cancer
owns Road, Surrey SM2 5PT,
uza).
. This is an open access article underIntroduction
With the introduction of screening programmes in the western
world, cancer of the cervix is being diagnosed at an increasingly early
stage. In women of a reproductive age, this has increased the demand
for fertility-sparing surgical options such as extended cone biopsy and
trachelectomy. The former is usually conﬁned to treating cervical
intra-epithelial neoplasia (CIN), carcinoma in situ or localised cases ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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sion (LVSI) [1,2]. If disease is more extensive but b2 cm in maximum
dimension, trachelectomy (pioneered by Dargent et al. [3] andmodiﬁed
by Shepherd et al. [4]) is consideredwhich involves cervical amputation
and excision of extracervical (lower parametrial) tissue with preserva-
tion of the uterine body and ovariesmaking subsequent pregnancy pos-
sible. A cuff of vaginal tissue (1–2 cm) is removed in addition to the
cervix and a primary vagino-isthmic/internal os anastomosis created.
During the procedure a frozen section of the superior (apical) resection
margin is sent to conﬁrm aminimum of 5 mm tumour clearance.When
patient selection is vigilant, radical vaginal trachelectomy with pelvic
lymph node dissection is similar in efﬁcacy in terms of oncological out-
come to radical hysterectomy with no signiﬁcant differences in 5-year
survival, 5-year progression-free survival rate and recurrence rates
[5–7].
In patients selected for trachelectomy, it is preferable to leave some
healthy cervical stroma in situ so that the risks of cervical incompetence,
infection, premature rupture of membranes and premature delivery in
subsequent pregnancies are reduced [8]. Most surgeons require 1 cm
of tumour free cervix proximal to the tumour but some will accept 5–
7 mm. Therefore, pre-operative assessment with MRI to determine the
maximum tumour diameter, volume and degree of endocervical
extension is of major importance [9–11]. In these small tumours
(b1 cm in maximum dimension) accuracy of detecting tumours is
improved using endovaginal T2-W MRI at 1.5 T [12–15] with further
improvements evident when diffusion-weighted techniques are added
[16]. However, correlation of tumour volume and length of uninvolved
endocervical canal in patients undergoing trachelectomy has not been
undertaken. Potentially also, extension of endovaginal T2-W and
diffusion-weighted techniques to 3.0 T offers further improvements in
spatial resolution. The purpose of this study, therefore, was to compare
MRI derived measurements of tumour size/volume and length of
uninvolved endocervical canal on T2-weighted images viewed in
conjunction with diffusion weighted sequences acquired using an
endovaginal technique at 3.0 Twithmeasurementsmade on trachelecto-




Over a 25 month period 55 consecutive patients aged 25–44 years
(mean± SD= 30.5 ± 4.9 years) with stage I cervical cancer diagnosed
on smear test or who presented with irregular bleeding or abnormal
vaginal discharge being considered for fertility-sparing surgery were
prospectively assessed with endovaginal MRI. Fifty patients had a
diagnostic large loop excision of the transformation zone (LLETZ) or
cone biopsy an average of 5.5 weeks (SD ± 2.8 weeks, range 0.5–
13 weeks) prior to the MRI study, at which all of the tumour may
have been excised.
Image acquisition
Endovaginal imageswere obtained on a 3.0-T Philips Achieva using a
37mm ring design solenoidal receiver coil similar to the one previously
described for use at 1.5-T [17] but engineered for 3.0 T. The coil was
inserted following digital vaginal examination and positioned around
the cervix. Air in the vagina introduced during coil insertion was
aspirated via a 4-mm diameter tube (Ryles; Pennine Healthcare,
London, England) to reduce susceptibility-based artefacts occurring at
the air–tissue interface. Each patient was examined supine and coil
immobilization achieved using an externally sited clamp with a stand
placed between the patients' thighs. Hyoscine butyl bromide (Buscopan)
20 mg IM was administered to reduce artefact from bowel motion.T2-W images (TR/TE = 4500/80 ms, acquisition matrix = 240, ﬁeld
of view=100mm, section thickness=2mmwith no intersection gap)
were obtained in three orthogonal planes to the cervix (sagittal, coronal
and transverse)with a 0.42mm in-plane resolution and0.36mm3 voxel
size (0.25 mm3 reconstructed). Zonal Oblique Multi-slice (ZOOM)
diffusion-weighted (DW) echo-planar images (TR/TE 6500/90, acquisi-
tion matrix = 80, ﬁeld of view = 100 mm) employing b values of 0,
100, 300, 500, and 800 s/mm2 were obtained in three planes to match
the T2-W images. In plane resolution = 1.25 mm, voxel size =
3.15 mm3 (0.41 mm3 reconstructed). Twenty four 2 mm thick sections
provided coverage of the cervix (acquisition time 4 min 33 s). Isotropic
ADC maps were generated with Phillips system software using all b
values. Following endovaginal imaging, the internal receiver coil was
removed and large ﬁeld of view images through the abdomen andpelvis
was obtained for assessment of the lymph nodes that did not form part
of this study.
Image analysis
T2-W and Zoom-DW images were assessed in combination for the
presence of tumour (intermediate signal-intensity focal mass on T2-W
imaging corresponding to a focal area of restriction on ZOOM-DW
imaging) by 2 observers in consensus (1 with 20 years' experience of
endovaginal MRI and 1 with 2 years' experience). In patients in whom
visible tumour was present on endovaginal MRI, andwho subsequently
proceeded to fertility-sparing surgery (further knife-cone biopsy or
trachelectomy), both observers on separate occasions independently
recordedmaximum tumour dimensions using an in built 3.0-Tworksta-
tion measuring tool and drawn on either the sagittal, coronal or axial
T2-weighted images with reference to the b = 800 s/mm2 diffusion
weighted images and correspondingADCmap (Fig. 1). Tumour volumes
were also recorded by drawing regions of interest (ROIs) around the
tumour on T2-weighted images in either the sagittal or coronal planes
(depending on which plane the tumour was most easily visible) with
reference to the b = 800 s/mm2 diffusion weighted images and corre-
sponding ADC map and multiplying the summed area of the tumour
ROI on each slice by the slice thickness. In addition, in these patients,
the distance from the superior aspect of the tumour to the internal os
was recorded on the sagittal T2-weighted images with reference to
the corresponding ADC map using the workstation measuring tool
(Fig. 2). All measurements were made blinded to the histological
ﬁndings.
Histopathological analysis
All specimens were ﬁxed in formalin and the entire specimen sub-
mitted for histology in the following manner: a shave of the proximal
endocervical resection margin (at or near the internal os) was obtained
and sliced longitudinally (usually in the sagittal plane centrally and the
coronal plane laterally). The cervix together with the parametrium was
then sliced into transverse sections up to approximately 1 cm from the
ectocervix. The remaining 1 cm of distal cervix together with vaginal
cuff was sectioned longitudinally (usually in the sagittal plane centrally
and the coronal plane laterally). All slices (each 3 to 4 mm thick) thus
obtained were processed and embedded in parafﬁn. Two to three
micron sections (obtained from the parafﬁn blocks on to glass slides)
were deparafﬁnised and stained with haematoxylin and eosin. Accord-
ing to the thickness of the slice obtained at macroscopy, each histology
slide was separated from the next by 3 to 4 mm.
Tumour volumes were calculated on trachelectomy histopathology
specimens using a technique similar to that used for imaging sections.
Slides that contained tumour had tumour outlined by a gynaecological
pathologist (AA or SH). The distance from the superior aspect of the
tumour to the proximal resection margin was measured and recorded.
Slides then were scanned or photographed at high resolution with an
overlying set scale (Canon CanoscanLiDE 200 MP Navigator EX 2.0 or
Fig. 1. Coronal T2-W (left), and corresponding b-800 s/mm2 (middle) and ADC map (right) slices showing a small tumour on the left cervical lip (arrows).
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viewed in Adobe Photoshop (CS3 Extended) and the area of the tumour
ROI (mm2) on each slicewhere it was visiblewasmultiplied by the slide
interval measurement (4 mm) to obtain a volume in cm3 (Fig. 3).
Statistical analysis
The sensitivity, speciﬁcity, positive and negative predictive values
for determining tumour in a population referred for fertility-sparing
surgery were determined. Maximum dimension of tumour, tumour
volume and the tumour to internal os distance on MRI measured by
independent observers were correlated between observers and be-
tween each observer and histology measurements using a Pearson's
correlation coefﬁcient where zero indicates no linear relationship
between the readings and 1.0 reﬂects a perfect linear relationship.
Differences between imaging and histology measurements were re-
corded using a paired t-test. A p value of less than 0.05 was used to in-
dicate signiﬁcance.
Results
Of the 55 patients referred for consideration of fertility sparing
treatment, 25 patients had a radical trachelectomy (1 after a further
knife cone), 19 patients had extended cone biopsy, 1 had a LLETZ, 3
had hysterectomy (2 lesion too large for trachelectomy, 1 endometri-
osis) and 7 went for chemoradiotherapy (6 staged as 2b, 1 neuroendo-
crine histology).Fig. 2.Measuring length of normal endocervical canal above tumour on sagittal T2-W images (
intensity mass in A and an area of restricted diffusion on the ADC map (arrows).Of the 45 patients that underwent fertility-sparing surgery, 15
patients had residual tumour (13 at trachelectomy (Fig. 4), 1 at cone
biopsy after MRI that was followed by a negative trachelectomy and 1
on extended cone biopsy only). Of these, 2 had no visible tumour on
MRI and tumour volume was recorded as zero. Six patients had tumour
recorded at MRI by observer 1 and 3 by observer 2, who were negative
on histology. Sensitivity and speciﬁcity for detecting tumour in the cohort
treated with fertility sparing surgery were 86.7% and 80.0%, respectively
(PPV 68.4%, NPV 92.3%) for observer 1 and 86.7% and 90% respectively
(PPV 81.0%, NPV 93.1%) for observer 2.Tumour size
In patients treated with fertility sparing surgery, maximum tumour
dimensions on histology in the 15 patients positive for tumour (13 true
positive [TP], 2 false negative [FN]) ranged from 1.5 mm to 30.0 mm
(mean± SD 11.3± 7.6mm,median 10.0 mm, IQR 6.1–14.8mm). Corre-
sponding MRI measurements were 0–38 mm (mean 14.2 ± 10.5 mm,
median 14.0 mm, IQR 8.5–18.5 mm) (observer 1) and 0 mm to
30.0 mm (mean ± SD = 13.3 ± 8.7 mm, median 12.0 mm, IQR 7.8–
18.9 mm) (observer 2). Detailed data were provided in Supplemental
material Table 1. For the whole cohort, the Pearson's correlation coefﬁ-
cient for maximum dimension of lesion between observers was 0.96.
The correlation between MRI and histology was 0.91 (observer 1) and
0.93 (observer 2) (p= b0.0001). Bland–Altman plots comparing differ-
ences in tumour maximal dimension between observers, and each
observer with histology are given in Fig. 5. Paired t-tests indicated noleft) with sagittal ADC maps (right) for reference. Tumour is seen an intermediate signal-
Fig. 3. Assessing tumour volume on histology. Coronal T2-W (top left), b-800 s/mm2 diffusion-weighted (topmiddle) and ADCmap (top right) images through themid cervix. Tumour is
outlined in T2-W with reference to diffusion-weighted images (arrow). The trachelectomy specimen with the tumour delineated (bottom left) is photographed with an overlying
millimetre grid (bottom right) and the area in mm2 calculated.
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histology (p = 0.09) or observer 2 and histology (p = 0.15).
Tumour volumetry
In the 15 cases positive for tumour (13 TP, 2FN), volumetry on
histology was possible in 13 (as 1 trachelectomy and 1 patient withFig. 4. Transverse T2-W(top left), b-800 s/mm2 (top right) andADCmap (bottom left) showing
trachelectomy specimen (bottom right).knife cone were operated elsewhere and the specimens were not
available for analysis). In these 13 cases tumour volumes on histology
ranged from 0.012 cm3 to 2.0 cm3 (mean± SD 0.62±0.67 cm3, median
0.28 cm3, IQR = 0.14–1.06 cm3). Corresponding MRI measurements
were 0–2.1 cm3 (mean ± SD 0.75 ± 0.72 cm3, median 0.5 cm3, IQR =
0.3–1.2 cm3) (observer 1) and 0 cm3 to 4.4 cm3 (mean ± SD 0.97 ±
1.3 cm3, median 0.35 cm3, IQR 0.13–1.04 cm3) (observer 2). Detaileda small tumour in theposterior endocervix (arrows) that correlateswith that shownon the
Fig. 5. Bland–Altman plots of variability in assessment of maximal tumour dimension between observers (left), between observer 1 and histology (middle) and between observer 2 and
histology (right). Dashed lines show the limits of agreement (95% conﬁdence intervals).
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cohort, the Pearson's correlation coefﬁcient for tumour volume was
0.84 between observers p= b0.0001. Although there was no signiﬁcant
difference between the volume measurements by either observer and
those on histology (paired t-test, p = 0.2 for both observers), there
was no signiﬁcant correlation demonstrated between MRI measured
volumes and those on histology (r = 0.08, p = 0.6, observer 1
and r = 0.21, p = 0.16, observer 2). Bland–Altman plots comparing
differences in tumour volume between observers, and each observer
with histology are given in Fig. 6.Assessment of endocervical canal
Comparison between MRI and histology estimates of endocervical
canal length was done in 19 cases who underwent trachelectomy and
in whom tumour was identiﬁed on MRI or histology (12 TP, 2 FN, 5
false positive [FP]); in one TP and 1 FP case who underwent knife cone,
this measurement could not be made. In true negative cases the clear-
ance of margins was not an issue. In these 19 cases, the length of the
endocervical canal (distance from the proximal aspect of the tumour to
the internal os) ranged from 8.0 to 32.0 mm (mean ± SD 19.0 ±
5.7 mm, median 20.0 mm, IQR 15.5–22.0 mm) (observer 1) and
6.0 mm to 27.0 mm (mean ± SD 18.9 ± 5.6 mm, median 19.6 mm,
IQR 17.1–21.6 mm) (observer 2). Measurements on histopathology
specimens for these patients from superior aspect of tumour to resection
margin ranged from 4.0 mm to 34.0 mm (mean ± SD 15.5 ± 8.5 mm,
median 17.5 mm, IQR 6.5–21.0 mm). There was no signiﬁcant difference
between MRI and histology measurements for length of endocervical
canal (paired t-test p = 0.1 for both observers). Detailed data provided
in Supplemental material Table 2.Fig. 6. Bland–Altman plots of variability in assessment of tumour volume between observers
(right). Dashed lines show the limits of agreement (95% conﬁdence intervals).Discussion
This study shows that measurements of tumour size and volume in
subcentimetre cervical cancers made on endovaginal T2-W images in
conjunction with DW images agree well between observers and
with the measurements made on the pathological specimen. This
technique is therefore ideal for pre-operative planning in patients
with stage Ia2/Ib1 cervical cancer where fertility sparing proce-
dures are being considered.
The excellent correlation in maximum tumour dimensions on MRI
with subsequent histopathological examination is in keeping with pre-
vious studies where external pelvic arrayMRI hasmeasured tumours of
larger size (70–93% accuracy to within 0.5 cm) in cohorts of patients
undergoing hysterectomy [18,19]. The increased signal-to-noise ratio
provided by an endovaginal receiver coil enables improved resolution
in order to identify and evaluate subcentimetre lesions. Similarly, the
volume at MRI also correlated signiﬁcantly with histopathology for
both observers in the 13 TP and 2 FN cases. In all but 3 cases tumour
volumes were larger in size and volume on endovaginal MRI than at
histology; 2 of these cases were falsely negative. In the third case
where the histological volumewas larger than onMRI, the time interval
fromMRI to surgerywas 59 days. It is remarkable that, in the remaining
12, despite a mean time interval between endovaginal MRI and surgery
of 41 days (range 9–89 days), tumour size/volume on histopathology
did not increase to greater than that measured on MRI.
The overestimation of tumour diameter onMRI compared to pathol-
ogy in previous studies (up to 19%) has been partly attributed to speci-
men shrinkage on formalin ﬁxation [20,21]. Ex vivo volume change in
surgical specimens is complicated. In the ﬁrst instance, loss in blood vol-
ume occurs. It also is known that resected tissue specimens containing
non-small cell lung cancer, breast cancer, vulvar and head and neck(left), between observer 1 and histology (middle) and between observer 2 and histology
331K. Downey et al. / Gynecologic Oncology 133 (2014) 326–332cancers shrink post formalin ﬁxation [22–24] as do normal colorectal
tissue specimens. It has been shown however that lateral resection
margins in resected rectal cancer specimens increase in diameter and
normal muscles of porcine models expand after formalin ﬁxation whilst
the fat of the same models shrink [25]. In the normal ﬁbro-muscular
cervix there are ex vivo changes both due to formalin ﬁxation leading
to dehydration (indeed retraction pockets of histopathological ‘retrac-
tion artefact’ were demonstrated in some tumours at histopathological
assessment where the stroma had contracted away from the epitheli-
um) but also due to the process of parafﬁn wax embedding, section
cutting and section mounting. Boonstra et al. found that there was
shrinkage of 2.7% in specimens following formalin ﬁxation and a change
from original dimensions by 12.6% in specimens following parafﬁn wax
embedding, cutting andmounting. It is postulated that the second value
is not due to shrinkage per se but deformation caused by pressure on the
tissue during sectioning. The dimensions decreased in the cutting direc-
tion and increased in a direction that was perpendicular to this [26].
Another explanation for the discrepancy betweenMRI and histolog-
ical ﬁndings is the inability to differentiate tumour from peritumoural
inﬂammatory tissue that is often increased following a diagnostic cone
biopsy [16]. However, the inclusion of inﬂammatory tissue on estimates
of lesion size/volume can be problematic on both MRI and histopathol-
ogy estimates. The addition of diffusion-weighted to T2-weighted
images should enable distinction between post biopsy change (such as
oedema, granulation tissue and ﬁbrosis) and tumour, because in the
former case, tissue does not show diffusion restriction, whereas restric-
tion of water diffusion is characteristic of tumour tissue [27,28]. Never-
theless, themedianpercentage difference betweenMRI and histology in
lesion size (26.7%) and volume (17.6%) in our cohort for observer 1 was
similar to previously reported data, although observer 2 did consider-
ably better (median 5% and 5% respectively).
Involvement of the internal os on MRI is poorly documented in
previous literature [29]. In our study, tumour was not documented
beyond the internal os onMRI in any case and these ﬁndings were con-
ﬁrmed at histology. The exact distance inmillimetres from the proximal
aspect of the tumour to the internal os at endovaginal MRI evaluation
did not however correlate well with subsequent histology because
surgical resection aimed to leave a rim of normal cervix in situ where
possible to reduce the risk of miscarriage of subsequent pregnancies.
The amount of this rimwas variable and dependent on patient anatomy.
Although comparisons of endocervical canal lengthwould best bemade
on hysterectomy specimens in order to accurately assess the cervical–
endometrial junction on histology, tumours in this population are
larger, easier to deﬁne on external coil MRI and often extend to the inter-
nal os, making them an unsuitable population for endovaginal MRI mea-
surements. Alternatively, validation of measurement of endocervical
canal length on endovaginal MRI could be done in patients with benign
disease due for hysterectomy by comparisonwithmacroscopic histologic
sections.
A major limitation to this study was that there were small patient
numbers with residual disease. In many cases, most (if not all) of the
tumour was removed at previous cone biopsy. Previous reports indicate
that 65% of patients do not have any residual cancer in trachelectomy
specimens after diagnostic cone biopsies [4,30]. Of the 45 patients
referred for trachelectomy who had subsequent surgery (and therefore
histopathology for assessment) in this cohort, 15 patients (33%) had
visible tumour on MRI. Whilst the negative predictive value is also
crucial for management decisions, it means that to achieve a particular
cohort size with residual disease, three times as many cases would
need to be studied.
This study demonstrates that in the assessment of subcentimetre
cervical cancers, endovaginal MRI using T2-W and diffusion-weighted
imaging has a high sensitivity and speciﬁcity for experienced as well
as inexperienced observers with good agreement between them for
measurements of lesion size and volume. Correlation between MRI
and histology is similar to that of other studies with larger tumoursthat do not use endovaginal imaging. EndovaginalMRI to deﬁne tumour
size and volume is likely to be of major utility in the selection of candi-
dates for fertility sparing treatment.Conﬂict of interest statement
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